Home › NDC Lookup › RxCUI directory › RxCUI 2390767

{2 (355 ML) (magnesium sulfate 0.0277 MEQ/ML / potassium sulfate 0.0374 MEQ/ML / sodium su... — RxCUI 2390767

RxNorm drug concept · Generic pack
RxCUI 2390767 Generic pack · GPCK ● Current RxNorm concept 8 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2390767
Official name{2 (355 ML) (magnesium sulfate 0.0277 MEQ/ML / potassium sulfate 0.0374 MEQ/ML / sodium sulfate 0.257 MEQ/ML Oral Solution) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
Also known as{2 (12 OZ magnesium sulfate 1.2 GM / potassium sulfate 2.35 GM / sodium sulfate 13.13 GM Oral Solution) } Pack
FDA products mapped8
Package NDCs mapped8
Reported Medicaid activity (SDUD)36,708 prescriptions · 39 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Magnesium Sulfate, Potassium Sulfate, and Sodium Sulfate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It cleans out your colon so your doctor can see clearly during a colonoscopy. It works as an osmotic laxative, pulling water into your bowel.
  • You take it in two doses. You drink one diluted bottle the evening before and one the morning of your colonoscopy, with extra water after each. Stop all fluids at least 2 hours bef...
  • Bloating, belly pain, nausea, vomiting and general discomfort are common. Call your doctor if you vomit a lot, feel dehydrated, have a seizure, notice an irregular heartbeat or see...
  • Take oral medicines at least 1 hour before each dose. Certain ones, like tetracycline and fluoroquinolone antibiotics, iron and digoxin, need more spacing. Avoid stimulant laxative...
📖 Read our full Magnesium Sulfate, Potassium Sulfate, and Sodium Sulfate guide →

🕸️ Concept Web — How {2 (355 ML) (magnesium sulfate 0.0277 MEQ/ML / p... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {2 (355 ML) (magnesium sulfate 0.0277 MEQ/ML / potassium sulfate 0.0374 MEQ/ML / sodium sulfate 0.257 MEQ/ML Oral Solution) } Pack RxCUI 2390767

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Magnesium sulfate 6585
    • Potassium sulfate 34323
    • Sodium sulfate 36721
    • Magnesium sulfate / potassium sulfate / sodium sulfate 1007809
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Magnesium sulfate / potassium sulfate / sodium sulfate Oral Solution 1001687
    • Magnesium sulfate / potassium sulfate / sodium sulfate Oral Liquid Product 1158053
    • Magnesium sulfate / potassium sulfate / sodium sulfate Oral Product 1158054
    • Pack 746839
    • Oral Liquid Product 1151137
    • Oral Product 1151131
  3. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  4. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 15 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

📦 FDA Products & Package NDCs

8 products · 8 package NDCs
8 package NDCs map to RxCUI 2390767 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
10572-0012-01 2 BOTTLE, PLASTIC in 1 CARTON (10572-012-01) / 177.4 mL in... SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE Affordable Pharmaceuticals, LLC 2010-08-05
10572-0112-01 2 BOTTLE, PLASTIC in 1 CARTON (10572-112-01) / 133.1 mL in... SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE Affordable Pharmaceuticals, LLC 2021-01-05
24338-0175-01 2 BOTTLE, PLASTIC in 1 CARTON (24338-175-01) / 177.4 mL in... SUPREP Bowel Prep Azurity Pharmaceuticals, Inc. 2026-04-01
24338-0177-01 2 BOTTLE, PLASTIC in 1 CARTON (24338-177-01) / 133.1 mL in... SUPREP Bowel Prep Azurity Pharmaceuticals, Inc. 2026-04-01
52268-0012-01 2 BOTTLE, PLASTIC in 1 CARTON (52268-012-01) / 177.4 mL in... SUPREP Bowel Prep Braintree Laboratories, Inc. 2010-08-05
52268-0112-01 2 BOTTLE, PLASTIC in 1 CARTON (52268-112-01) / 133.1 mL in... SUPREP Bowel Prep Braintree Laboratories, Inc. 2021-01-05
52536-0175-01 2 BOTTLE, PLASTIC in 1 CARTON (52536-175-01) / 177.4 mL in... SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE Wilshire Pharmaceuticals, Inc. 2026-04-15
52536-0177-01 2 BOTTLE, PLASTIC in 1 CARTON (52536-177-01) / 133.1 mL in... SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE Wilshire Pharmaceuticals, Inc. 2026-04-15
Observed labelers: Affordable Pharmaceuticals, LLC (2) · Azurity Pharmaceuticals, Inc. (2) · Braintree Laboratories, Inc. (2) · Wilshire Pharmaceuticals, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.